Literature DB >> 11086030

The proinflammatory mediator macrophage migration inhibitory factor induces glucose catabolism in muscle.

F Benigni1, T Atsumi, T Calandra, C Metz, B Echtenacher, T Peng, R Bucala.   

Abstract

Severe infection or tissue invasion can provoke a catabolic response, leading to severe metabolic derangement, cachexia, and even death. Macrophage migration inhibitory factor (MIF) is an important regulator of the host response to infection. Released by various immune cells and by the anterior pituitary gland, MIF plays a critical role in the systemic inflammatory response by counterregulating the inhibitory effect of glucocorticoids on immune-cell activation and proinflammatory cytokine production. We describe herein an unexpected role for MIF in the regulation of glycolysis. The addition of MIF to differentiated L6 rat myotubes increased synthesis of fructose 2,6-bisphosphate (F2,6BP), a positive allosteric regulator of glycolysis. Increased expression of the enzyme 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFK-2) enhanced F2,6BP production and, consequently, cellular lactate production. The catabolic effect of TNF-alpha on myotubes was mediated by MIF, which served as an autocrine stimulus for F2, 6BP production. TNF-alpha administered to mice decreased serum glucose levels and increased muscle F2,6BP levels; pretreatment with a neutralizing anti-MIF mAb completely inhibited these effects. Anti-MIF also prevented hypoglycemia and increased muscle F2,6BP levels in TNF-alpha-knockout mice that were administered LPS, supporting the intrinsic contribution of MIF to these inflammation-induced metabolic changes. Taken together with the recent finding that MIF is a positive, autocrine stimulator of insulin release, these data suggest an important role for MIF in the control of host glucose disposal and carbohydrate metabolism.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11086030      PMCID: PMC381433          DOI: 10.1172/JCI9900

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  56 in total

Review 1.  Mammalian 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase: a bifunctional enzyme that controls glycolysis.

Authors:  G G Rousseau; L Hue
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1993

2.  Tumor necrosis factor acutely increases plasma levels of very low density lipoproteins of normal size and composition.

Authors:  R M Krauss; C Grunfeld; W T Doerrler; K R Feingold
Journal:  Endocrinology       Date:  1990-09       Impact factor: 4.736

3.  Tumor necrosis factor enhances glucose uptake by peripheral tissues.

Authors:  D A Evans; D O Jacobs; D W Wilmore
Journal:  Am J Physiol       Date:  1989-11

4.  Lethal hypoglycemia and hypothermia induced by administration of low doses of tumor necrosis factor to adrenalectomized rats.

Authors:  T Chajek-Shaul; V Barash; J Weidenfeld; G Friedman; E Ziv; E Shohami; E Shiloni
Journal:  Metabolism       Date:  1990-03       Impact factor: 8.694

5.  Human recombinant IL-1 alters glucocorticoid receptor function in Reuber hepatoma cells.

Authors:  M R Hill; R D Stith; R E McCallum
Journal:  J Immunol       Date:  1988-09-01       Impact factor: 5.422

6.  Molecular cloning of a cDNA encoding a human macrophage migration inhibitory factor.

Authors:  W Y Weiser; P A Temple; J S Witek-Giannotti; H G Remold; S C Clark; J R David
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

Review 7.  Tumor necrosis factor: an updated review of its biology.

Authors:  K J Tracey; A Cerami
Journal:  Crit Care Med       Date:  1993-10       Impact factor: 7.598

Review 8.  Fructose 2,6-bisphosphate and the control of glycolysis by growth factors, tumor promoters and oncogenes.

Authors:  L Hue; G G Rousseau
Journal:  Adv Enzyme Regul       Date:  1993

9.  Tumor necrosis factor mimics the metabolic response to acute infection in healthy humans.

Authors:  T Van der Poll; J A Romijn; E Endert; J J Borm; H R Büller; H P Sauerwein
Journal:  Am J Physiol       Date:  1991-10

10.  Chronic intraperitoneal infusion of low doses of tumor necrosis factor alpha in rats induces a reduction in plasma triglyceride levels.

Authors:  C G Sweep; R M Hermus; M J van der Meer; P N Demacker; T J Benraad; P W Kloppenborg; J W van der Meer
Journal:  Cytokine       Date:  1992-11       Impact factor: 3.861

View more
  39 in total

1.  The viral theory of schizophrenia revisited: abnormal placental gene expression and structural changes with lack of evidence for H1N1 viral presence in placentae of infected mice or brains of exposed offspring.

Authors:  S Hossein Fatemi; Timothy D Folsom; Robert J Rooney; Susumu Mori; Tess E Kornfield; Teri J Reutiman; Rachel E Kneeland; Stephanie B Liesch; Kegang Hua; John Hsu; Divyen H Patel
Journal:  Neuropharmacology       Date:  2011-01-26       Impact factor: 5.250

Review 2.  Macrophage migration inhibitory factor (MIF): a promising biomarker.

Authors:  Gerrit Grieb; Melanie Merk; Jürgen Bernhagen; Richard Bucala
Journal:  Drug News Perspect       Date:  2010-05

3.  "Remote" myokine protects from pulmonary ischemia/reperfusion injury by a surprising "proximal" control mechanism.

Authors:  Jürgen Bernhagen
Journal:  Ann Transl Med       Date:  2018-07

4.  Inflammatory cytokine gene polymorphisms increase the risk of atrophic gastritis and intestinal metaplasia.

Authors:  Zhong-Wu Li; Ying Wu; Yu Sun; Lu-Ying Liu; Meng-Meng Tian; Guo-Shuang Feng; Wei-Cheng You; Ji-You Li
Journal:  World J Gastroenterol       Date:  2010-04-14       Impact factor: 5.742

Review 5.  Genetics of acute and chronic pancreatitis: An update.

Authors:  Vv Ravi Kanth; D Nageshwar Reddy
Journal:  World J Gastrointest Pathophysiol       Date:  2014-11-15

6.  Distinct Secretory Activity and Clinical Impact of Subcutaneous Abdominal Adipose Tissue in Women with Rheumatoid Arthritis and Osteoarthritis.

Authors:  Ewa Kontny; Agnieszka Zielińska; Urszula Skalska; Krystyna Księżopolska-Orłowska; Piotr Głuszko; Włodzimierz Maśliński
Journal:  Inflammation       Date:  2017-02       Impact factor: 4.092

7.  Serum macrophage migration inhibitory factor is an early marker of pancreatic necrosis in acute pancreatitis.

Authors:  Sakhawat H Rahman; Krishna V Menon; John H M Holmfield; Michael J McMahon; J Pierre Guillou
Journal:  Ann Surg       Date:  2007-02       Impact factor: 12.969

Review 8.  [Pathomechanisms of organ failure. Mitochondrial dysfunction in sepsis].

Authors:  M Wendel; A R Heller; T Koch
Journal:  Anaesthesist       Date:  2009-04       Impact factor: 1.041

9.  Cardiac macrophage migration inhibitory factor inhibits JNK pathway activation and injury during ischemia/reperfusion.

Authors:  Dake Qi; Xiaoyue Hu; Xiaohong Wu; Melanie Merk; Lin Leng; Richard Bucala; Lawrence H Young
Journal:  J Clin Invest       Date:  2009-11-16       Impact factor: 14.808

Review 10.  Macrophage migration inhibitory factor: critical role in obesity, insulin resistance, and associated comorbidities.

Authors:  Robert Kleemann; Richard Bucala
Journal:  Mediators Inflamm       Date:  2010-02-09       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.